VectorBuilder
Latest round
- Series C
Last raised
- Mar 2023
Total raised
- $58M
Investors
- 7
About VectorBuilder
Established in 2014 and based in Guangzhou, China, VectorBuilder operates as a scientific research customized carrier supplier that provides gene delivery solutions. Bruce Lahn is the founder and chief scientist of professorship at the University of Chicago and the researcher at the Howard Hughes Medical Institute (HHMI). In February 2022, Pall Corporation has become the strategic partner of VectorBuilder. The strategic investment values the company at CNY 7 billion post-money. The company provides gene delivery solutions, including virus packaging, protein expression and in vitro transcription. The business of the company includes customized services of scientific research carrier, CRO service, CDMO service and property right export business. CDMO service includes plasmid DNA, viral vector and mRNA. Its products include shRNA libraries, dual-gRNA CRISPR libraries, EGFP and HiExpress™, luciferase IVT mRNA and AAV virus-like particles (VLPs). VectorBuilder's carrier systems include lentivirus, adenovirus, AAV, HSV and VSV.73 million.
Who invested in VectorBuilder
7 investors across 3 rounds
See all investors in VectorBuilder
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about VectorBuilder
Who invested in VectorBuilder?
VectorBuilder has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has VectorBuilder raised?
VectorBuilder has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did VectorBuilder last raise money?
VectorBuilder's most recent round on record is a Series C, in Mar 2023.
What does VectorBuilder do?
Established in 2014 and based in Guangzhou, China, VectorBuilder operates as a scientific research customized carrier supplier that provides gene delivery solutions.
Where is VectorBuilder headquartered?
VectorBuilder is headquartered in Guangzhou, China.
Which VCs invest in companies like VectorBuilder?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at VectorBuilder's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like VectorBuilder? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.